1,3,5-Triazine-2,4,6-triamine,N2,N2,N4,N4,N6,N6-hexamethyl-
			
			
				 
- 中文别名:六甲密胺
- 中文释义:六甲蜜胺;六甲三聚氰胺;2,4,6-三(二甲氨基)均三嗪;六甲聚腈胺
- 英文别名:hexamethylmelamine;
 Altretamine;
 Hexalen;
 Hexastat;
 NC 195;
 N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine;
 N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine;
 HMM;
 N,N,N’,N’,N″,N″-hexamethyl-1,3,5-triazine-2,4,6-triamine;
 altretamine;
 HTM;
 Hemel;
 2,4,6-tris-1,3,5-triazine;
 Hexylen;
 hemel
- CAS No.:645-05-6
- 分子式:C9H18N6 
- 分子量:210.28
- 精确分子量:210.15900
- PSA:48.39000
- MDL:MFCD00549245
- InChI:InChI=1/C9H24N6/c1-10(2)13-7-14(11(3)4)9-15(8-13)12(5)6/h7-9H2,1-6H3
- 分子结构式:  
 
			物化性质
- 外观与性状:
- 无色结晶固体
- 密度:
- 1.148 g/cm3
- 熔点:
- 171-175 °C(lit.)
- 沸点:
- 301ºC
- 闪点:
- 159.1ºC
- 水溶解性:
- Insoluble
- 折射率:
- 1.569
- 存储条件/存储方法:
- 常温,2-8℃,避光,通风干燥处 
- 稳定性相关:
- 白色针状结晶。熔点170-173℃,易溶于 - 氯仿,微溶于甲醇、乙醇,极微溶于水,对酸碱稳定。具升华性 
- 其它信息:
- 1. 性状:白色针状结晶 - 2. 密度(g/mL,25/4℃): - 3. 相对蒸汽密度(g/mL,空气=1): - 4. 熔点(ºC):171-175 - 5. 沸点(ºC,常压):301 - 6. 沸点(ºC,5.2kPa):未确定 - 7. 折射率: - 8. 闪点(ºC): - 9. 比旋光度(º): - 10. 自燃点或引燃温度(ºC):  - 11. 蒸气压(kPa,25ºC): - 12. 饱和蒸气压(kPa,60ºC):  - 13. 燃烧热(KJ/mol): - 14. 临界温度(ºC):  - 15. 临界压力(KPa):  - 16. 油水(辛醇/水)分配系数的对数值:  - 17. 爆炸上限(%,V/V): - 18. 爆炸下限(%,V/V):  - 19. 溶解性:不溶于水 
安全信息
- 外观与性状:
- 无色结晶固体
- 密度:
- 1.148 g/cm3
- 熔点:
- 171-175 °C(lit.)
- 沸点:
- 301ºC
- 闪点:
- 159.1ºC
- 水溶解性:
- Insoluble
- 折射率:
- 1.569
- 存储条件/存储方法:
- 常温,2-8℃,避光,通风干燥处 
- 稳定性相关:
- 白色针状结晶。熔点170-173℃,易溶于 - 氯仿,微溶于甲醇、乙醇,极微溶于水,对酸碱稳定。具升华性 
- 其它信息:
- 1. 性状:白色针状结晶 - 2. 密度(g/mL,25/4℃): - 3. 相对蒸汽密度(g/mL,空气=1): - 4. 熔点(ºC):171-175 - 5. 沸点(ºC,常压):301 - 6. 沸点(ºC,5.2kPa):未确定 - 7. 折射率: - 8. 闪点(ºC): - 9. 比旋光度(º): - 10. 自燃点或引燃温度(ºC):  - 11. 蒸气压(kPa,25ºC): - 12. 饱和蒸气压(kPa,60ºC):  - 13. 燃烧热(KJ/mol): - 14. 临界温度(ºC):  - 15. 临界压力(KPa):  - 16. 油水(辛醇/水)分配系数的对数值:  - 17. 爆炸上限(%,V/V): - 18. 爆炸下限(%,V/V):  - 19. 溶解性:不溶于水 
毒理性
CHEMICAL IDENTIFICATION
 - RTECS NUMBER :
- OS1050000
- CHEMICAL NAME :
- Melamine, hexamethyl-
- CAS REGISTRY NUMBER :
- 645-05-6
- BEILSTEIN REFERENCE NO. :
- 0195058
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 26
- MOLECULAR FORMULA :
- C9-H18-N6
- MOLECULAR WEIGHT :
- 210.33
- WISWESSER LINE NOTATION :
- T6N CN ENJ BN1&1 DN1&1 FN1&1
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
 - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human
- DOSE/DURATION :
- 8 mg/kg
- TOXIC EFFECTS :
- Gastrointestinal - nausea or vomiting   Blood - leukopenia
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 350 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 265 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 437 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - chromodacryorrhea   Blood - hemorrhage
- TYPE OF TEST :
- LD10 - Lethal Dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 200 mg/kg
- TOXIC EFFECTS :
- Blood - granulocytopenia   Blood - changes in bone marrow (not otherwise specified)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 171 mg/kg
- TOXIC EFFECTS :
- Cardiac - cardiomyopathy including infarction   Liver - hepatitis (hepatocellular necrosis), zonal
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Blood - pigmented or nucleated red blood cells   Blood - changes in leukocyte (WBC) count   Biochemical - Enzyme inhibition, induction, or change in blood or tissue   levels - transaminases
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 255 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Bird - chicken
- DOSE/DURATION :
- 341 mg/kg
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - flaccid paralysis without anesthesia   (usually neuromuscular blockage)   Behavioral - ataxia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3080 mg/kg/77D-I
- TOXIC EFFECTS :
- Gastrointestinal - changes in structure or function of endocrine pancreas   Endocrine - hyperglycemia   Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 625 mg/kg/5D-I
- TOXIC EFFECTS :
- Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 625 mg/kg/5D-I
- TOXIC EFFECTS :
- Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 250 mg/kg/5D-I
- TOXIC EFFECTS :
- Blood - changes in bone marrow (not otherwise specified)   Blood - other changes   Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 3108 mg/kg/3Y-I
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria   Blood - leukemia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 7 gm/kg/46W-C
- TOXIC EFFECTS :
- Tumorigenic - neoplastic by RTECS criteria   Kidney, Ureter, Bladder - Kidney tumors   Skin and Appendages - tumors
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1240 mg/kg
- SEX/DURATION :
- male 62 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - testes, epididymis, sperm duct   Reproductive - Fertility - male fertility index (e.g. # males impregnating   females per # males exposed to fertile nonpregnant females)   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or   resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 320 mg/kg
- SEX/DURATION :
- female 6-9 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or   resorbed implants per total number of implants)   Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured   before birth)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 320 mg/kg
- SEX/DURATION :
- female 9-12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,   e.g., stunted fetus)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1160 mg/kg
- SEX/DURATION :
- female 15-22 day(s) after conception  lactating female 21 day(s) post-birth
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4   per # born alive)   Reproductive - Effects on Newborn - weaning or lactation index (e.g., #   alive at weaning per # alive at day 4)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 80 mg/kg
- SEX/DURATION :
- female 15-22 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight   gain)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 780 mg/kg
- SEX/DURATION :
- female 6-18 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,   e.g., stunted fetus)
- TYPE OF TEST :
- Sex chromosome loss and nondisjunction
- TYPE OF TEST :
- Cytogenetic analysis
MUTATION DATA
 - TYPE OF TEST :
- DNA damage
- TEST SYSTEM :
- Mammal - species unspecified Lymphocyte
- DOSE/DURATION :
- 250 umol/L
- REFERENCE :
- CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut   Sts., Philadelphia, PA 19106)  V.1-    1941-  Volume(issue)/page/year:   43,500,1983
 - 生态数据:
- 通常对水是不危害的,若无政府许可,勿将材料排入周围环境 
海关数据
中国海关编码:2933699090
- 概述:
- 2933699090 其他结构上含非稠合三嗪环化合物. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:20.0%
- 申报要素:
- 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
- 摘要/Summary:
- 2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0%
分子结构与计算化学数据
计算化学数据
1.疏水参数计算参考值(XlogP):无
2.氢键供体数量:0
3.氢键受体数量:6
4.可旋转化学键数量:3
5.互变异构体数量:无
6.拓扑分子极性表面积48.4
7.重原子数量:15
8.表面电荷:0
9.复杂度:148
10.同位素原子数量:0
11.确定原子立构中心数量:0
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1